(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -9.00%-82.54K | 4.52%-50.53K | 31.52%-43.17K | 2.68%-245.66K | 36.07%-53.98K | -63.60%-75.73K | 24.37%-52.92K | -21.86%-63.04K | -37.76%-252.42K | -74.10%-84.43K |
Net income from continuing operations | -150.01%-153.18K | 12.41%-54K | 15.34%-51.3K | -19.01%-282.67K | -63.99%-99.17K | 14.44%-61.27K | -28.76%-61.65K | -5.27%-60.59K | 39.97%-237.51K | -25.83%-60.47K |
Asset impairment expenditure | ---- | ---- | ---- | --34.95K | ---- | ---- | ---- | ---- | --0 | ---- |
Change In working capital | -74.87%-25.29K | -60.28%3.47K | 433.27%8.14K | 113.83%2.06K | 142.74%10.24K | -157.13%-14.46K | 139.49%8.73K | -141.86%-2.44K | -151.69%-14.91K | -5,407.36%-23.96K |
-Change in receivables | -73.96%-22.64K | -10.78%18.57K | 24.40%-2.42K | 120.82%2.11K | 4.80%-2.48K | -157.67%-13.02K | 795.95%20.81K | -754.60%-3.2K | -131.30%-10.16K | -43.55%-2.6K |
-Change in payables and accrued expense | -83.01%-2.65K | -24.96%-15.1K | 1,288.82%10.56K | 98.88%-53 | 153.45%12.72K | -104.41%-1.45K | 36.75%-12.08K | -85.77%760 | -31.51%-4.75K | -1,825.74%-23.8K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -9.00%-82.54K | 4.52%-50.53K | 31.52%-43.17K | 2.68%-245.66K | 36.07%-53.98K | -63.60%-75.73K | 24.37%-52.92K | -21.86%-63.04K | -37.76%-252.42K | -74.10%-84.43K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 48.35%-79K | -154.37%-181.65K | -25K | -389.44%-152.95K | -420.22%-71.41K | 0 | ||||
Net PPE purchase and sale | ---- | ---- | ---- | -154.37%-181.65K | ---- | ---- | ---- | ---- | ---71.41K | ---- |
Net other investing changes | 48.35%-79K | ---- | ---- | ---- | ---- | -389.44%-152.95K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 48.35%-79K | ---- | ---- | -154.37%-181.65K | ---25K | -389.44%-152.95K | ---- | ---- | -420.22%-71.41K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 250K | 50K | -56.03%137.6K | 0 | 137.6K | 0 | 0 | 312.97K | 0 |
Net common stock issuance | --0 | --250K | --50K | -56.03%137.6K | --0 | --137.6K | --0 | --0 | --312.97K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --250K | --50K | -56.03%137.6K | --0 | --137.6K | --0 | --0 | --312.97K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -18.23%173.84K | -81.66%49.37K | -87.20%42.53K | -3.17%332.24K | -70.84%121.51K | -56.99%212.58K | -52.28%269.21K | -3.17%332.24K | -31.93%343.11K | 26.53%416.67K |
Current changes in cash | -77.37%-161.54K | 319.82%124.47K | 110.84%6.84K | -2,566.98%-289.71K | 6.46%-78.98K | -17.46%-91.08K | 19.07%-56.63K | -128.51%-63.04K | 93.25%-10.86K | -711.44%-84.43K |
End cash Position | -89.88%12.29K | -18.23%173.84K | -81.66%49.37K | -87.20%42.53K | -87.20%42.53K | -70.84%121.51K | -56.99%212.58K | -52.28%269.21K | -3.17%332.24K | -3.17%332.24K |
Free cash from | -9.00%-82.54K | 4.52%-50.53K | 31.52%-43.17K | -31.96%-427.31K | -51.20%-235.63K | -63.60%-75.73K | 24.37%-52.92K | -21.86%-63.04K | -76.73%-323.83K | -221.36%-155.84K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data